AZN · story · 11 November – 12 November
AstraZeneca · 8 headlines from 6 outlets, from 11 November 2026 to 12 November 2026.
Nine out of ten analyst firms increased their price targets for AstraZeneca after Q3, and coverage of the results carried on.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
Biostock is the largest at 10.0, ahead of Kalkine Media (8.3). Yahoo Finance is the smallest at 2.9.
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| TradingView | 7.9 |
| Biostock | 10.0 |
| Kalkine Media | 8.3 |
| Pluang | 7.5 |
| Seeking Alpha | 6.7 |
| Yahoo Finance | 2.9 |
| Outlet | Headlines | Average tone |
|---|---|---|
| TradingView | 2 | +7.9 |
| Biostock | 1 | +10.0 |
| Kalkine Media | 1 | +8.3 |
| Pluang | 1 | +7.5 |
| Seeking Alpha | 1 | +6.7 |
| Yahoo Finance | 2 | +2.9 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| +10.0 | Broad analyst target increases after quarterly results. |
| +10.0 | Most analyst houses lifted targets after quarter. |
| +8.3 | Core earnings rising again after results. |
| +7.5 | Specialty medicines supporting growth despite pressures. |
| +6.7 | Cancer franchise growth more than offsets a declining product. |
| +5.8 | Quarterly growth and outlook, with a win and setbacks. |
| Tone | What the article reported, and why it scored that way |
|---|---|
| +5.0 | Guidance maintained and pipeline seen as strong, with valuation upside. |
| +0.8 | Analyst targets split, valuation estimate slightly higher. |
A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.